Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt asset resilience ratio. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has an Asset Resilience Ratio of 0.20% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Richter Gedeon Vegyészeti Gyár Nyilvános defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
Asset resilience ratio of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2025. This chart shows how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's Asset Resilience Ratio has changed over time. Read RIG2 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Richter Gedeon Vegyészeti Gyár Nyilvános balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.14 Billion | 0.2% |
| Total Liquid Assets | €3.14 Billion | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Industry Peers by Asset Resilience Ratio
Compare Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Asset Resilience Ratio by Year (2013–2025)
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.73% | €46.34 Billion ≈ $54.18 Billion |
€1.70 Trillion ≈ $1.99 Trillion |
+2.67pp |
| 2024-12-31 | 0.06% | €994.00 Million ≈ $1.16 Billion |
€1.61 Trillion ≈ $1.88 Trillion |
-0.50pp |
| 2023-12-31 | 0.57% | €7.69 Billion ≈ $8.99 Billion |
€1.36 Trillion ≈ $1.59 Trillion |
-2.89pp |
| 2022-12-31 | 3.45% | €46.25 Billion ≈ $54.07 Billion |
€1.34 Trillion ≈ $1.57 Trillion |
+3.37pp |
| 2021-12-31 | 0.08% | €912.00 Million ≈ $1.07 Billion |
€1.15 Trillion ≈ $1.34 Trillion |
-0.67pp |
| 2020-12-31 | 0.75% | €7.14 Billion ≈ $8.35 Billion |
€948.59 Billion ≈ $1.11 Trillion |
+0.57pp |
| 2019-12-31 | 0.18% | €1.54 Billion ≈ $1.81 Billion |
€858.65 Billion ≈ $1.00 Trillion |
-0.41pp |
| 2018-12-31 | 0.59% | €4.73 Billion ≈ $5.53 Billion |
€797.88 Billion ≈ $932.81 Billion |
+0.59pp |
| 2017-12-31 | 0.00% | €18.00 Million ≈ $21.04 Million |
€760.87 Billion ≈ $889.53 Billion |
-0.09pp |
| 2016-12-31 | 0.09% | €751.00 Million ≈ $878.00 Million |
€813.88 Billion ≈ $951.51 Billion |
-0.44pp |
| 2015-12-31 | 0.53% | €3.97 Billion ≈ $4.64 Billion |
€746.99 Billion ≈ $873.31 Billion |
-2.37pp |
| 2014-12-31 | 2.90% | €20.87 Billion ≈ $24.40 Billion |
€720.06 Billion ≈ $841.82 Billion |
+2.36pp |
| 2013-12-31 | 0.53% | €3.82 Billion ≈ $4.46 Billion |
€714.14 Billion ≈ $834.91 Billion |
-- |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more